COPENHAGEN/LONDON (Reuters) -Years before Novo Nordisk's obesity drug Wegovy became ... great communicator," said Frank Horning Andersen, a former analyst at Jyske Bank who covered Novo during ...

In the late 2010s, scientists at the Danish drugmaker Novo Nordisk developed a new weekly ... promising obesity drug candidates. For some former Novo employees, the little-known episode is ...

Former CEO of Novo Nordisk for 16 years and current chair of the Novo Nordisk Foundation, Lars Rebien Sorensen, will join the board as an observer with immediate effect with the aim of taking a ...

Lars Rebien Sørensen, current chair of the foundation and former CEO of Novo Nordisk, will join the company's board as an observer. He is expected to be nominated as a board member at the 2026 ...

Despite the leadership change, Novo Nordisk said its strategy remains unchanged, with former CEO and Novo Nordisk foundation Chair Lars Rebien Sørensen set to join the company’s board as an ...

Novo CEO ousted by majority shareholder Novo Nordisk Foundation Foundation chair ... great communicator," said Frank Horning Andersen, a former analyst at Jyske Bank who covered Novo during ...